About the Study

Wilms Tumors: A study of Combination Chemotherapy

This study is being done for children and adults: • 30 years old or younger. • Diagnosed with Diffuse Anaplastic Wilms Tumor (DAWT) or Relapsed Favorable Histology Wilms Tumor (FHWT) In this study, we want to find out if we can improve treatment for patients with newly diagnosed DAWT and those with high-risk or very high-risk relapsed FHWT. Patients on study will be given a combination of chemotherapy drugs plus radiation therapy.

Interested in learning more?

Full Study Name: AREN1921 - Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)